We are live on ! Find out more
JAM

JW Asset Management Portfolio holdings

AUM $244M
1-Year Est. Return 71.51%
This Fund
S&P 500
This Quarter Est. Return
+42.62%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$231M
AUM Growth
+$98M
Cap. Flow
+$63.2M
Cap. Flow %
27.33%
Top 10 Hldgs %
69.94%
Holding
63
New
6
Increased
32
Reduced
6
Closed
16

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$21.7M
2
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$18M
3
BWLD
Buffalo Wild Wings, Inc.
BWLD
+$5.72M
4
BX icon
Blackstone
BX
+$4.96M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$4.65M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$8.13M
2
TARO
Taro Pharmaceutical Industries Ltd.
TARO
+$4.19M
3
AMZN icon
Amazon
AMZN
+$731K
4
CPRI icon
Capri Holdings
CPRI
+$714K
5
AGN
Allergan Inc
AGN
+$432K

Sector Composition

Rank Sector Weight
1 Healthcare 70.28%
2 Technology 9.76%
3 Consumer Discretionary 6.88%
4 Financials 6.74%
5 Communication Services 1.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EGRX
1
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$30.8M 13.32%
735,542
+633,719
+622% +$18M
AAPL icon
2
Apple
AAPL
$5.05T
$22.4M 9.69%
+720,000
New +$21.7M
REGN icon
3
Regeneron Pharmaceuticals
REGN
$72.9B
$21.4M 9.24%
47,338
+10,983
+30% +$4.65M
HZNP
4
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$18.9M 8.19%
729,609
+148,925
+26% +$2.73M
BX icon
5
Blackstone
BX
$105B
$15.6M 6.74%
408,086
+137,175
+51% +$4.96M
AGN
6
DELISTED
Allergan plc
AGN
$12.1M 5.22%
40,594
+6,068
+18% +$1.73M
TARO
7
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$11.2M 4.86%
79,685
-27,246
-25% -$4.19M
INSY
8
DELISTED
Insys Therapeutics, Inc.
INSY
$10.9M 4.7%
374,236
-7,818
-2% -$207K
AVDL
9
DELISTED
Avadel Pharmaceuticals
AVDL
$9.92M 4.29%
551,562
+56,408
+11% +$883K
LCI
10
DELISTED
Lannett Company, Inc.
LCI
$8.52M 3.68%
31,440
+2,192
+7% +$498K
BWLD
11
DELISTED
Buffalo Wild Wings, Inc.
BWLD
$7.85M 3.4%
43,328
+30,831
+247% +$5.72M
JAZZ icon
12
Jazz Pharmaceuticals
JAZZ
$16.1B
$5.61M 2.42%
32,436
+3,819
+13% +$655K
ALXN
13
DELISTED
Alexion Pharmaceuticals
ALXN
$5.58M 2.42%
32,229
+8,021
+33% +$1.45M
PRGO icon
14
Perrigo
PRGO
$1.45B
$4.47M 1.94%
27,031
+1,866
+7% +$298K
SLXP
15
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$3.82M 1.65%
22,096
+13,056
+144% +$1.92M
AKRX
16
DELISTED
Akorn Inc
AKRX
$3.54M 1.53%
74,606
+24,091
+48% +$1.09M
BIIB icon
17
Biogen
BIIB
$30.7B
$3.42M 1.48%
8,104
+4,235
+109% +$1.67M
ANIP icon
18
ANI Pharmaceuticals
ANIP
$1.85B
$3.16M 1.37%
50,553
+28,029
+124% +$1.7M
JNP
19
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$3.1M 1.34%
498,767
+93,411
+23% +$578K
TSLA icon
20
Tesla
TSLA
$1.2T
$2.83M 1.22%
225,000
-602,175
-73% -$8.13M
CMG icon
21
Chipotle Mexican Grill
CMG
$44B
$2.79M 1.21%
214,750
+112,450
+110% +$1.53M
LGND icon
22
Ligand Pharmaceuticals
LGND
$5.79B
$2.7M 1.17%
56,135
+3,674
+7% +$141K
SGNT
23
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$2.59M 1.12%
111,385
+7,902
+8% +$209K
MNK
24
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$2.26M 0.98%
17,876
+6,912
+63% +$790K
ENDP
25
DELISTED
Endo International plc
ENDP
$1.98M 0.86%
22,085
+10,087
+84% +$844K
1
2 3

Similar funds

SC
Schulhoff & Co Cincinnati, Ohio $243M AUM 17.47% 1-Year Est. Return
HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
IFO
Independent Family Office Albany, New York $243M AUM 21.81% 1-Year Est. Return
VG
Visualize Group New York $243M AUM 6.21% 1-Year Est. Return
CP
Creekside Partners Petaluma, California $243M AUM 20.23% 1-Year Est. Return

JW Asset Management's Q1 2015 Portfolio in Review

As of Q1 2015, JW Asset Management held 63 positions worth $231M, up 74% from $133M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

JW Asset Management deployed $63.2M of net new capital in Q1 2015, opening 6 new positions and adding to 32 existing holdings. Its largest new stake was Apple: 720,000 shares worth $22.4M.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, down from 74% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $8.13M trimmed.

  • JW Asset Management's largest Q1 2015 buy was Apple: 720,000 shares worth $22.4M.
  • JW Asset Management added most to Eagle Pharmaceuticals, Inc. in Q1 2015, an estimated $18M increase.
  • JW Asset Management's biggest Q1 2015 reduction was Tesla, cutting an estimated $8.13M.
  • JW Asset Management fully exited Capri Holdings in Q1 2015, selling an estimated $714K.
  • JW Asset Management's ten largest holdings make up 70% of its $231M portfolio in Q1 2015.
  • JW Asset Management opened 6 new positions and closed 16 in Q1 2015.
  • JW Asset Management's portfolio value rose 74% quarter-over-quarter to $231M.

Based on JW Asset Management's 13F filing for Q1 2015, filed 15 May 2015.